AMPLIFYING THE VOICES

Our Life With MCT8 Deficiency

MCT8 deficiency (Allan-Herndon-Dudley syndrome [AHDS]) is a rare disorder that causes health complications requiring lifelong support for daily activities.

If you’re affected by MCT8 deficiency, you don’t need to face the challenges alone. This space brings together voices from people with the disorder, their caregivers, and doctors, all working to amplify understanding and hope within the MCT8 community.

Explore this page to hear real voice of people who shared “Our Life With MCT8 Deficiency.” If you want to add your experience to the chorus of support, learn how to share your story.

CAREGIVERS, DOCTORS, AND EGETIS THERAPEUTICS SPEAK UP

About MCT8 Deficiency

  • MCT8 Deficiency Symptoms (1 min, 17 sec)
  • MCT8 Deficiency Causes (48 sec)
  • Recognizing Symptoms & Testing (1 min, 40 sec)
  • Multidisciplinary Care Team (1 min, 33 sec)
  • Research & Clinical Trials (1 min)

Real Experiences and Support

  • Nicole and Her Son Liam (58 sec)
  • Liam’s Diagnosis (1 min, 4 sec)
  • Nicole Early Experience (43 sec)
  • Getting Care for Liam (1 min, 19 sec)
  • Nicole Gets Caregiver Support (44 sec)
  • Jennifer and Her Son Colten (1 min, 40 sec)
  • MCT8-AHDS Foundation & Egetis Therapeutics (4 min, 44 sec)
  • Nicole & Liam Find Joy (39 sec)

Watch the full episode of Behind the Mystery™, a recurring series from The Balancing Act® devoted to advocating for rare and genetic diseases or explore the video chapters.

In this video, you’ll hear:

  • Nicole, caregiver and advocate for her son, Liam, shares the emotional story of finally receiving his diagnosis
  • Jennifer, caregiver and advocate for her son, Colten, discusses their story and the MCT8-AHDS Foundation
  • Larry Fox, MD, talks about the signs, symptoms, and causes of MCT8 deficiency
  • Andrew J Bauer, MD, discusses MCT8 deficiency research and the paths to diagnosis
  • Amy Bedard, President North America, Egetis Therapeutics, discusses working together to address unmet needs of people with MCT8 deficiency
Caregivers of Children With MCT8 Deficiency Make Their Voices Count

“Egetis Therapeutics is driven by three key pillars: Courage, Commitment, and Collaboration. We have the courage to tackle hard conditions like MCT8 deficiency, commitment to uphold the highest ethical standards, and value ongoing collaboration with the MCT8 community to heighten awareness and understanding of MCT8 deficiency. Currently, there are no approved medicines for MCT8 deficiency in the United States, creating a high unmet need we’re diligently working to address.”

—Anny Bedard, President North America, Egetis Therapeutics
Megaphone icon.

SUPPORT OTHERS: ADD YOUR VOICE TO “OUR LIFE WITH MCT8 DEFICIENCY”

Learn more about how you can share your story about MCT8 deficiency.

LEARN MORE